CLL: Treatment and Management Strategies for Best Outcomes - Episode 8
Focusing on acalabrutinib-based treatment, Yuliya Linhares, MD, discusses results from the ELEVATE TN clinical trial.
Related Content:
After 11 Years With Cancer, What Is Enough Time?
How Therapeutic Vaccines May Transform Lung Cancer Care
How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma
It’s Okay Not To Be Okay Through a Cancer Diagnosis